12:00 AM
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Architect HbA1c regulatory update

Abbott received CE Mark approval for its Architect HbA1c (IA) assay to quantitatively determine the percent...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >